A Phase I, Randomized Double-blind, Placebo-controlled, Single-center, Single-dose, Three-way Cross-over Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Lacosamide Tablets in Healthy Male Chinese and Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy; Fibromyalgia; Migraine; Osteoarthritis; Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors UCB
- 22 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2011 New trial record